Drugmakers, hospitals at odds over 340B discounts

02/12/2013 | New York Times (tiered subscription model), The

The pharmaceutical industry and hospitals are fighting over the federally mandated 340B drug discount program. Some hospitals use the program as a revenue source instead of helping poor patients, BIO and other industry groups say in a report. Hospitals argue that 340B was designed to stretch resources and support hospitals that serve the poor. Congressional Republicans and looking into the program.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC